Get started
Altimmune, Inc.
Long

Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND f

By RocketTickers
ALT: Altimmune, Inc
2022-01-31 07:00:00
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity
Beyond Technical Analysis
RocketTickers

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.